BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 35272024)

  • 1. pH/ROS dual-responsive supramolecular polypeptide prodrug nanomedicine based on host-guest recognition for cancer therapy.
    Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Chen T; Dong CM; Yao Y
    Acta Biomater; 2022 Apr; 143():381-391. PubMed ID: 35272024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microenvironment responsive polypeptide-based supramolecular nanoprodrugs for combination therapy.
    Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Dong CM; Yao Y
    Acta Biomater; 2022 Jul; 146():396-405. PubMed ID: 35470074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ROS-sensitive thioketal-linked polyphosphoester-doxorubicin conjugate for precise phototriggered locoregional chemotherapy.
    Pei P; Sun C; Tao W; Li J; Yang X; Wang J
    Biomaterials; 2019 Jan; 188():74-82. PubMed ID: 30336287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nanomedicine composed of polymer-ss-DOX and polymer-Ce6 prodrugs with monoclonal antibody targeting effect for anti-tumor chemo-photodynamic synergetic therapy.
    Yu L; Zhang M; He J; Sun X; Ni P
    Acta Biomater; 2024 Apr; 179():272-283. PubMed ID: 38460931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimuli-Sensitive Linear-Dendritic Block Copolymer-Drug Prodrug as a Nanoplatform for Tumor Combination Therapy.
    Cai H; Tan P; Chen X; Kopytynski M; Pan D; Zheng X; Gu L; Gong Q; Tian X; Gu Z; Zhang H; Chen R; Luo K
    Adv Mater; 2022 Feb; 34(8):e2108049. PubMed ID: 34875724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-Amplified pH/ROS Dual-Responsive Co-Delivery Nano-System with Chemo-Photodynamic Combination Therapy in Hepatic Carcinoma Treatment.
    Huang Y; Wu S; Li J; He C; Cheng Y; Li N; Wang Y; Wu Y; Zhang J
    Int J Nanomedicine; 2024; 19():3737-3751. PubMed ID: 38699684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-Sensitive self-assembling nanoparticles for tumor near-infrared fluorescence imaging and chemo-photodynamic combination therapy.
    Hou W; Zhao X; Qian X; Pan F; Zhang C; Yang Y; de la Fuente JM; Cui D
    Nanoscale; 2016 Jan; 8(1):104-16. PubMed ID: 26607263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactivatable reactive oxygen species-sensitive nanoparticulate system for chemo-photodynamic therapy.
    Kim Y; Uthaman S; Pillarisetti S; Noh K; Huh KM; Park IK
    Acta Biomater; 2020 May; 108():273-284. PubMed ID: 32205212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamically assembled nanomedicine based on host-guest molecular recognition for NIR laser-excited chemotherapy and phototheranostics.
    Wu D; Zhang Z; Li X; Zhou J; Cao Y; Qi S; Wang L; Liu Z; Yu G
    Acta Biomater; 2023 Sep; 168():565-579. PubMed ID: 37481192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH/ROS Dual-Responsive Polymer-Drug-Based Nanocarriers: Click-Reaction Preparation and Fluorescence Imaging-Guided Chemotherapy and Photodynamic Therapy.
    Zhang N; Wang D; Jing X; Yang T; Yang H; Meng L
    ACS Appl Bio Mater; 2021 Aug; 4(8):6294-6303. PubMed ID: 35006916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH/ROS dual stimuli-responsive anionic flexible supramolecular organic frameworks for synergistic therapy.
    Yin Y; Gao L; Sun P; Zeng L; Zhao Q; Chen S; Liu J; Wang L
    Acta Biomater; 2023 Dec; 172():395-406. PubMed ID: 37866724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near-Infrared Light Triggered ROS-activated Theranostic Platform based on Ce6-CPT-UCNPs for Simultaneous Fluorescence Imaging and Chemo-Photodynamic Combined Therapy.
    Yue C; Zhang C; Alfranca G; Yang Y; Jiang X; Yang Y; Pan F; de la Fuente JM; Cui D
    Theranostics; 2016; 6(4):456-69. PubMed ID: 26941840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of light/ROS cascade-responsive tumor-recognizing nanotheranostics for spatiotemporally controlled drug release in locoregional photo-chemotherapy.
    Zuo W; Chen D; Fan Z; Chen L; Zhu Z; Zhu Q; Zhu X
    Acta Biomater; 2020 Jul; 111():327-340. PubMed ID: 32434075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood circulation stable doxorubicin prodrug nanoparticles containing hydrazone and thioketal moieties for antitumor chemotherapy.
    Xu C; Xu L; Han R; Zhu Y; Zhang J
    Colloids Surf B Biointerfaces; 2021 May; 201():111632. PubMed ID: 33667865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Chemo-Photodynamic Combination Platform Based on the DOX Prodrug Nanoparticles for Enhanced Cancer Therapy.
    Zhang Y; Huang F; Ren C; Yang L; Liu J; Cheng Z; Chu L; Liu J
    ACS Appl Mater Interfaces; 2017 Apr; 9(15):13016-13028. PubMed ID: 28378992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROS-Activated nanoscale coordination polymers for enhanced ultrasound-mediated therapy for the treatment of cancer.
    Zhao J; Shi J; Meng X; Gong C; Wu P; Yang Z; Dong H
    Acta Biomater; 2022 Apr; 143():372-380. PubMed ID: 35219868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ROS triggered cleavage of thioketal moiety to dissociate prodrug nanoparticles for chemotherapy.
    Pan Q; Deng X; Gao W; Chang J; Pu Y; He B
    Colloids Surf B Biointerfaces; 2020 Oct; 194():111223. PubMed ID: 32615519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer.
    Yi H; Lu W; Liu F; Zhang G; Xie F; Liu W; Wang L; Zhou W; Cheng Z
    J Nanobiotechnology; 2021 May; 19(1):134. PubMed ID: 33975609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.
    Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R
    Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone-Targeting Prodrug Mesoporous Silica-Based Nanoreactor with Reactive Oxygen Species Burst for Enhanced Chemotherapy.
    Tong F; Ye Y; Chen B; Gao J; Liu L; Ou J; van Hest JCM; Liu S; Peng F; Tu Y
    ACS Appl Mater Interfaces; 2020 Aug; 12(31):34630-34642. PubMed ID: 32635715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.